4.87 USD
-0.05 (-1.02%)
Taking everything into account, NEPH scores 5 out of 10 in our fundamental rating. NEPH was compared to 130 industry peers in the Machinery industry. NEPH has an excellent financial health rating, but there are some minor concerns on its profitability. NEPH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
NEPH had positive earnings in the past year.
NEPH had a positive operating cash flow in the past year.
In the past 5 years NEPH reported 4 times negative net income.
NEPH had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
NEPH's Return On Assets of 10.84% is amongst the best of the industry. NEPH outperforms 83.85% of its industry peers.
Looking at the Return On Equity, with a value of 13.82%, NEPH is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
NEPH's Return On Invested Capital of 10.62% is fine compared to the rest of the industry. NEPH outperforms 75.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| ROIC | 10.62% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NEPH has a better Profit Margin (7.95%) than 66.15% of its industry peers.
Looking at the Operating Margin, with a value of 8.01%, NEPH is in line with its industry, outperforming 50.00% of the companies in the same industry.
NEPH has a Gross Margin of 63.37%. This is amongst the best in the industry. NEPH outperforms 98.46% of its industry peers.
NEPH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.01% | ||
| PM (TTM) | 7.95% | ||
| GM | 63.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NEPH is still creating some value.
Compared to 1 year ago, NEPH has about the same amount of shares outstanding.
Compared to 5 years ago, NEPH has more shares outstanding
Compared to 1 year ago, NEPH has a worse debt to assets ratio.
2.2 Solvency
NEPH has an Altman-Z score of -2.21. This is a bad value and indicates that NEPH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.21, NEPH is not doing good in the industry: 86.92% of the companies in the same industry are doing better.
The Debt to FCF ratio of NEPH is 0.01, which is an excellent value as it means it would take NEPH, only 0.01 years of fcf income to pay off all of its debts.
NEPH's Debt to FCF ratio of 0.01 is amongst the best of the industry. NEPH outperforms 93.08% of its industry peers.
NEPH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, NEPH belongs to the top of the industry, outperforming 86.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | -2.21 |
ROIC/WACC1.12
WACC9.44%
2.3 Liquidity
NEPH has a Current Ratio of 5.41. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NEPH (5.41) is better than 93.08% of its industry peers.
NEPH has a Quick Ratio of 4.14. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
NEPH's Quick ratio of 4.14 is amongst the best of the industry. NEPH outperforms 93.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.41 | ||
| Quick Ratio | 4.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 244.44% over the past year.
Looking at the last year, NEPH shows a decrease in Revenue. The Revenue has decreased by -0.53% in the last year.
Measured over the past years, NEPH shows a small growth in Revenue. The Revenue has been growing by 6.51% on average per year.
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%
3.2 Future
The Earnings Per Share is expected to grow by 13281452764.99% on average over the next years. This is a very strong growth
NEPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.15% yearly.
EPS Next Y1322977426536356900%
EPS Next 2Y13281452764.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.58%
Revenue Next 2Y17.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 37.46, the valuation of NEPH can be described as expensive.
Based on the Price/Earnings ratio, NEPH is valued a bit more expensive than 65.38% of the companies in the same industry.
NEPH is valuated rather expensively when we compare the Price/Earnings ratio to 25.45, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 79.58 indicates a quite expensive valuation of NEPH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 70.77% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.46. NEPH is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.46 | ||
| Fwd PE | 79.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NEPH is valued a bit more expensive than 73.08% of the companies in the same industry.
NEPH's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.85 | ||
| EV/EBITDA | 31.51 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEPH's earnings are expected to grow with 13281452764.99% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y13281452764.99%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NEPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:NEPH (11/21/2025, 8:00:02 PM)
4.87
-0.05 (-1.02%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners45.82%
Inst Owner Change-99.42%
Ins Owners10.73%
Ins Owner Change0.7%
Market Cap51.62M
Revenue(TTM)14.16M
Net Income(TTM)1.33M
Analysts82.5
Price Target7.14 (46.61%)
Short Float %0.11%
Short Ratio0.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)629.41%
Min EPS beat(2)178.43%
Max EPS beat(2)1080.39%
EPS beat(4)4
Avg EPS beat(4)438.24%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)205.3%
EPS beat(12)7
Avg EPS beat(12)116.27%
EPS beat(16)9
Avg EPS beat(16)82.79%
Revenue beat(2)2
Avg Revenue beat(2)24.79%
Min Revenue beat(2)18.66%
Max Revenue beat(2)30.93%
Revenue beat(4)3
Avg Revenue beat(4)13.61%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)2.81%
Revenue beat(12)5
Avg Revenue beat(12)1.07%
Revenue beat(16)6
Avg Revenue beat(16)-1.54%
PT rev (1m)27.27%
PT rev (3m)27.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)125%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.46 | ||
| Fwd PE | 79.58 | ||
| P/S | 3.09 | ||
| P/FCF | 25.85 | ||
| P/OCF | 25.85 | ||
| P/B | 5.38 | ||
| P/tB | 6.21 | ||
| EV/EBITDA | 31.51 |
EPS(TTM)0.13
EY2.67%
EPS(NY)0.06
Fwd EY1.26%
FCF(TTM)0.19
FCFY3.87%
OCF(TTM)0.19
OCFY3.87%
SpS1.57
BVpS0.91
TBVpS0.78
PEG (NY)0
PEG (5Y)N/A
Graham Number1.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| ROCE | 12.77% | ||
| ROIC | 10.62% | ||
| ROICexc | 20.6% | ||
| ROICexgc | 27.01% | ||
| OM | 8.01% | ||
| PM (TTM) | 7.95% | ||
| GM | 63.37% | ||
| FCFM | 11.97% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score7
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 0% | ||
| Cap/Sales | 0% | ||
| Interest Coverage | 668.5 | ||
| Cash Conversion | 135.12% | ||
| Profit Quality | 150.49% | ||
| Current Ratio | 5.41 | ||
| Quick Ratio | 4.14 | ||
| Altman-Z | -2.21 |
F-Score7
WACC9.44%
ROIC/WACC1.12
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y1322977426536356900%
EPS Next 2Y13281452764.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%
Revenue Next Year24.58%
Revenue Next 2Y17.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y197.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1326.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1326.43%
OCF growth 3YN/A
OCF growth 5YN/A
NEPHROS INC / NEPH FAQ
What is the fundamental rating for NEPH stock?
ChartMill assigns a fundamental rating of 5 / 10 to NEPH.
What is the valuation status of NEPHROS INC (NEPH) stock?
ChartMill assigns a valuation rating of 2 / 10 to NEPHROS INC (NEPH). This can be considered as Overvalued.
Can you provide the profitability details for NEPHROS INC?
NEPHROS INC (NEPH) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for NEPH stock?
The Earnings per Share (EPS) of NEPHROS INC (NEPH) is expected to grow by 1322977426536356900% in the next year.